RICHSTONE ELLEN B 4
4 · COGNITION THERAPEUTICS INC · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
Cognition Therapeutics (CGTX) Director Ellen Richstone Receives Award
What Happened
Director Ellen B. Richstone received a grant of 25,000 restricted stock units (RSUs) from Cognition Therapeutics (CGTX) on June 17, 2026. The grant was reported on a Form 4 filed June 22, 2026. Each RSU represents a contingent right to one share upon settlement; the grant shows a $0.00 acquisition price and no immediate cash proceeds.
Key Details
- Transaction date: 2026-06-17; Form 4 filed: 2026-06-22 (appears late — Form 4s are normally due within 2 business days).
- Transaction type/code: Award/Grant (A).
- Amount granted: 25,000 RSUs at $0.00 (no immediate cash value listed).
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) the date of the issuer’s next annual meeting of stockholders, subject to the Reporting Person’s continuous service as a director as of the applicable vesting date.
Context
RSUs are compensation that convert into shares only upon settlement/vesting, so this grant does not represent an open‑market purchase or sale. Such awards are common for director compensation and are intended for retention; they do not by themselves indicate an insider buying or selling shares on the open market.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-17+25,000→ 83,500 total
Footnotes (1)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.